Silence Therapeutics plc (SLN) › Cash & EquivalentsSilence Therapeutics plc (SLN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $68.79M2024: $121.33M2025: $11.28M$11.28M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$11.28M-90.7%2024$121.33M+76.4%2023$68.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share